A kind of refining method of novel antibiotic compound

Abstract

The invention relates to a purifying method of a novel antibiotic compound. The method includes: (1) a step of salifying, namely a step of adding cefazedone and sodium isooctoate into absolute methanol and performing a salifying reaction until the cefazedone is fully dissolved, with the temperature being controlled at 15-35 DEG C; (2) a step of decoloring, namely a step of adding active carbon into the reaction solution, stirring, decoloring, filtering to remove the active carbon, maintaining the temperature of the filtrate at 10-30 DEG C, and filtering again; (3) a step of crystallizing, namely a step of adding a certain amount of acetone and ethyl acetate into the filtrate after the filtration, controlling the temperature at 15-20 DEG C, growing the grain for 1-2 h, then adding a certain amount of the acetone and the ethyl acetate, stirring for crystallization with the stirring speed being maintained at 80-120 r / min, controlling the temperature at 15-25 DEG C, and growing the grain for 2-4 h; and (4) a step of drying, namely a step of filtering, washing the filter cake, and drying to obtain a purified product of the cefazedone sodium. Compared with the prior art, the method has characteristics of simple operation, low cost, high yield, and largely reduced pollution. The purified product of the cefazedone sodium has characteristics of low water content, low purity content and high stability.

Description

technical field

[0001] The invention belongs to the technical field of medicine, and relates to a method for refining a novel antibiotic compound, in particular to a method for refining a cefazedone sodium compound. Background technique

[0002] Infectious diseases are a common and frequently-occurring disease in clinical practice. According to the report of the World Health Organization (WHO), the number of deaths from infectious diseases is as high as 33.3% of the total number of deaths from various causes. Cephalosporins are the most widely used first-line drugs in clinical practice. In recent years, due to the abuse of antibiotics, many "super bacteria" have emerged, and the problem of bacterial drug resistance has become increasingly serious. The "Administrative Measures for the Clinical Application of Antibacterial Drugs" officially implemented by the state restricts the clinical application of the third-generation and fourth-generation cephalosporins with strong alt...

Images